BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29970678)

  • 1. The total number of lymph nodes harvested from pathological T3N0 rectal cancer patients: Prognostic significance and potential indication for postoperative radiotherapy.
    Xiao WW; Zhang LN; You KY; Huang R; Yu X; Chang H; Ding PR; Gao YH
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S288-S294. PubMed ID: 29970678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
    Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
    Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
    Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
    Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor location as an indication for adjuvant radiotherapy in pT3N0 rectal cancer after surgery.
    Peng HH; Zhou XH; Zhou TC; Qiu XS; You KY
    Radiat Oncol; 2019 Jan; 14(1):8. PubMed ID: 30651116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In the era of total mesorectal excision: adjuvant radiotherapy may be unnecessary for pT3N0 rectal cancer.
    Wu JX; Wang Y; Chen N; Chen LC; Bai PG; Pan JJ
    Radiat Oncol; 2014 Jul; 9():159. PubMed ID: 25052511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of total lymph node harvest in patients with T2-4N0M0 colorectal cancer.
    Tsai HL; Lu CY; Hsieh JS; Wu DC; Jan CM; Chai CY; Chu KS; Chan HM; Wang JY
    J Gastrointest Surg; 2007 May; 11(5):660-5. PubMed ID: 17468927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.
    Scabini S; Montecucco F; Nencioni A; Zoppoli G; Sartini M; Rimini E; Massobrio A; De Marini L; Poggi A; Boaretto R; Romairone E; Ballestrero A; Ferrando V
    World J Surg Oncol; 2013 Nov; 11():292. PubMed ID: 24246069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma.
    Tsai CJ; Crane CH; Skibber JM; Rodriguez-Bigas MA; Chang GJ; Feig BW; Eng C; Krishnan S; Maru DM; Das P
    Cancer; 2011 Aug; 117(16):3713-22. PubMed ID: 21328329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
    Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of lymph node ratios in node positive rectal cancer treated with preoperative chemoradiation.
    Nadoshan JJ; Omranipour R; Beiki O; Zendedel K; Alibakhshi A; Mahmoodzadeh H
    Asian Pac J Cancer Prev; 2013; 14(6):3769-72. PubMed ID: 23886180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lymph node ratio and number on survival in patients with rectal adenocarcinoma after preoperative chemo radiation.
    Bhatti ABH; Akbar A; Hafeez A; Syed AA; Khattak S; Jamshed A; Kazmi AS
    Int J Surg; 2015 Jan; 13():65-70. PubMed ID: 25475873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer.
    Jung W; Kim K; Kim J; Shim SJ
    In Vivo; 2020; 34(3):1247-1253. PubMed ID: 32354915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy.
    Beresford M; Glynne-Jones R; Richman P; Makris A; Mawdsley S; Stott D; Harrison M; Osborne M; Ashford R; Grainger J; Al-Jabbour J; Talbot I; Mitchell IC; Meyrick Thomas J; Livingstone JI; McCue J; MacDonald P; Northover JA; Windsor A; Novell R; Wallace M; Harrison RA
    Clin Oncol (R Coll Radiol); 2005 Sep; 17(6):448-55. PubMed ID: 16149289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer.
    Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC
    Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.